Ophthalmologists will find in this Postgraduate certificate the perfect opportunity to increase their specialization and improve the care of their patients with retinal pathologies"

Ophthalmology specialists have little training in pediatric retina, therefore, offering a high-level academic program such as the one we present on this occasion will allow them to specialize in a field of high demand, but which, in turn, has a great need for training. This program will deal in detail with the different retinal pathologies that can affect the pediatric age. 

The program begins with the analysis and study of hereditary retinal degenerations. Since the FDA approval of the drug Luxturna for the treatment of RPE65-spectrum DHRs, which was the first step on a giant ladder in the treatment of diseases of genetic origin, these pathologies have undergone a revolution, becoming spearheads of new knowledge and treatment.  

The submacular injection of the drug is able to repair by injecting a virus that carries the deficient genetic code that the patient suffers from. Its high success rate and the technological load of this treatment have brought out of the attic a group of diseases that are destined to become fashionable due to their therapeutic change.  

The program has a teaching staff specialized in ocular pathology and surgery, who contribute both their practical experience in their day to day private practice and their long teaching experience at national and international level. Additionally, it has the advantage of being a 100% online specialization, so the student can decide when and where to study.  

The planning of the program includes the participation of a renowned International Guest Director. With solid experience in research, this professional will share with the students the most recent developments in the area of pathologies and surgical procedures of the macula, retina and vitreous, with a Masterclass. 

Improve your professional or academic profile by attending this Masterclass led by a prestigious International Guest Director specialized in Ophthalmology” 

This Postgraduate certificate in Hereditary Retinal Dystrophies and Pediatric Retinal Pathology contains the most complete and up-to-date scientific program on the market.The most important features include:

• The development of clinical cases presented by experts in ocular pathology and surgery.
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice.
• The presentation of practical workshops on procedures and techniques.
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course.
• Action protocols and clinical practice guidelines, which cover the most important latest developments in this specialist field.
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Special emphasis on test-based medicine and research methodologies.
• Content that is accessible from any fixed or portable device with an Internet connection

This Postgraduate certificate is the best investment you can make in a program to update your knowledge in Hereditary Retinal Dystrophies and Pediatric Retinal Pathology”

The teaching staff includes a team of prestigious physicians, who bring their experience to this educational program, as well as renowned specialists from leading scientific societies. 

Its multimedia content, developed with the latest educational technology, will allow professionals to learn in a contextual and situated learning environment, i.e., a simulated environment that will provide immersive specialization for real situations. 

The design of this program focuses on Problem-Based Learning, by means of which professionals must try to solve the different professional practice situations that are presented to them throughout the course. For this purpose, they will be assisted by an innovative interactive video system developed by renowned experts in hereditary retinal dystrophies and pediatric retinal pathology, with extensive teaching experience. 

This 100% online Postgraduate certificate will allow you to study from anywhere in the world. All you need is a computer or mobile device with an Internet connection"

Our innovative teaching methodology will allow you to study as if you were dealing with real cases, and therefore increasing your education"

The structure of the curriculum has been designed by a team of professionals who are familiar with the implications of medical training in the approach to the patient, aware of the relevance of the current specialization and committed to quality teaching through new educational technologies. 

We offer you the most complete and updated scientific program on the market”

Module 1. Hereditary Retinal Dystrophies and Pediatric Retinal Pathology

1.1. Hereditary Retinal Dystrophies

1.1.1. Clinical Diagnosis. In-Office Tests and Campimetry
1.1.2. Imaging Tests, OCT and Angio OCT, Autofluorescence (AF), Fluorescein Angiography and Indocyanine Green
1.1.3. Electrophysiological Study

1.1.3.1. Generalized Photoreceptor Dystrophies
1.1.3.2. Macular Dystrophies
1.1.3.3. Generalized Choroidal Dystrophies
1.1.3.4. Hereditary Vitreoretinopathies
1.1.3.5. Albinism

1.1.4. HRD in the Pediatric Age Group, Main Signs and Symptoms
1.1.5. Genetic Basis of HRD
1.1.6. Clinical Classification of HRD

1.1.6.1. Introduction
1.1.6.2. HRD and Non-Syndromic Vitreoretinal

1.1.6.2.1. Rod Diseases

1.1.6.2.1.1. Stationary: Stationary Night Blindness. Normal and Abnormal Fundus (Fundus Albipunctatus and Oguchi Disease)
1.1.6.2.1.2. Progressives: Retinitis Pigmentosa (RP) or Cone-Rod Dystrophies (CRD)

1.1.6.2.2. Cone Diseases

1.1.6.2.1.1. Stationary or Cone Dysfunctions: Congenital Achromatopsia
1.1.6.2.2.2. Cone and Cone–Rod Dystrophies (CRD)

1.1.6.2.3. Macular Dystrophies

1.1.6.2.3.1. Stargardt/Fundus Flavimaculatus
1.1.6.2.3.2. Best's Disease
1.1.6.2.3.3. Central Areolar Choroidal Dystrophy (CACD)
1.1.6.2.3.4. X-Linked Juvenile Retinoschisis
1.1.6.2.3.5. Other Macular Dystrophies

1.1.6.2.4. Widespread Photoreceptor Diseases

1.1.6.2.4.1. Choroideremia
1.1.6.2.4.2. Atrophy Gyrate

1.1.6.2.5. Exudative and Non-Exudative Vitreoretinopathies

1.1.6.3. Syndromic HRD

1.1.6.3.1. Usher Syndrome
1.1.6.3.2. Bardet Biedl Syndrome
1.1.6.3.3. Senior Loken Syndrome
1.1.6.3.4. Refsum’s Disease
1.1.6.3.5. Joubert’s Disease
1.1.6.3.6. Alagille’s Disease
1.1.6.3.7. Alström's Syndrome
1.1.6.3.8. Neuronal Ceroid Lipofuscinosis
1.1.6.3.9. Primary Ciliary Dyskinesia (PCD)
1.1.6.3.10. Stickler’s Disease

1.1.7. HRD Treatment

1.1.7.1. Gene Therapy. A New Future for Treating Diseases with Genetic Alterations. Luxturna
1.1.7.2. Neurotrophic Growth Factor Therapies
1.1.7.3. Cell Therapy
1.1.7.4. Artificial Vision
1.1.7.5. Other Treatments

1.2. Retinopathy of Prematurity

1.2.1. Introduction and Historical Recollection
1.2.2. ROP Classification
1.2.3. Disease Context and Risk Factors
1.2.4. Diagnosis, Screening and Follow-up Guidelines in ROP
1.2.5. ROP Treatment Criteria
1.2.6. Using Anti-Vascular Endothelium Grown Factor
1.2.7. Use of Laser Treatment Today
1.2.8. Treatment by Scleral Surgery and/or Vitrectomy in Advanced Stages
1.2.9. Sequelae and Complications Arising from ROP
1.2.10. Criteria for Discharge and Subsequent Follow-up
1.2.11. Accountability, Documentation and Communication
1.2.12. Future of Screening and New Treatment Options
1.2.13. Medical-Legal Considerations BORRAR

1.3. Albinism

1.3.1. Introduction and Definitions
1.3.2. Examination and Clinical Findings
1.3.3. Natural History
1.3.4. Treatment and Management of Albino Patients

1.4. X-Linked Congenital Retinoschisis

1.4.1. Definition, Genetical Study and Family Tree
1.4.2. Examination and Clinical Findings
1.4.3. Electrophysiological Tests
1.4.4. Classification
1.4.5. Natural History and Genetic Counselling
1.4.6. Treatment Guidelines According to Staging

1.5. Best's Disease

1.5.1. Definition, Genetic Study
1.5.2. Diagnosis, Clinical Findings, Imaging Tests
1.5.3. Functional Testing, Microperimetry and Electrophysiological Testing
1.5.4. Natural History, Clinical Course
1.5.5. Current and Future Treatments for Best's Disease

1.6. Stargardt's Disease, Fundus Flavimaculatus

1.6.1. Definition and Genetic Study
1.6.2. Clinical Findings in Consultation, Imaging Tests
1.6.3. Electrophysiological Tests
1.6.4. Evolutionary History and Genetic Counselling
1.6.5. Current Treatments

1.7. Familial Exudative Vitreoretinopathy. (FEVR) 

1.7.1. Definition, Genetic Study
1.7.2. FEVR Clinical Findings
1.7.3. Imaging Tests, OCT, AngioOCT. AFG
1.7.4. Natural History and Progression of the Disease, Staging
1.7.5. FEVR Laser Treatment
1.7.6. Treatment with FEVR Vitrectomy
1.7.7. Treating Complications

1.8. Persistent Fetal Vasculature Syndrome. (PFVS) 

1.8.1. Definition and Evolution of Disease Nomenclature
1.8.2. Ultrasound Examination, Imaging Tests
1.8.3. Clinical Findings in Consultation
1.8.4. Treatment Guidelines and Staging
1.8.5. Surgical Treatment of PFVS. Vitrectomy
1.8.6. Natural and Evolutionary History of the Disease
1.8.7. Visual Rehabilitation

1.9. Coat’s Disease

1.9.1. Definition of Coat’s Disease. Evolving Forms
1.9.2. Clinical Findings in Consultation
1.9.3. Imaging Studies, Retinography, AFG, OCT AngioOCT
1.9.4. Ocular Ultrasound in Coat’s Disease
1.9.5. Treatment Spectrum According to the Developmental Form. Natural History
1.9.6. Laser Treatment and Cryotherapy
1.9.7. Treatment by Vitrectomy in Advanced Forms
1.9.8. Visual Rehabilitation

1.10. Norrie's Disease

1.10.1. Definition, Genetic Study
1.10.2. Clinical Findings in Consultation
1.10.3. Treatment Guidelines and Genetic Counselling Treatment Guidelines and Current Pharmaceuticals
1.10.4. Natural and Evolutionary History of Norrie’s Disease

1.11. Incontinentia Pigmenti

1.11.1. Definition and Genetic Study
1.11.2. Clinical Findings and Functional Tests
1.11.3. Natural and Evolutionary History of the Disease
1.11.4. Current Therapeutic Possibilities, Visual Aids

1.12. Choroidal Neovascularisation in the Pediatric Age Group

1.12.1. Clinical Findings in Consultation
1.12.2. Basic Functional and Imaging Tests
1.12.3. Differential Diagnosis
1.12.4. Treatment Guidelines and Their Possibilities According to Age

1.13. Retinal Detachment in the Pediatric Age and Detachment Associated with Ocular Coloboma

1.13.1. General Considerations
1.13.2. Anatomy and Surgical Adaptation to Retinal Detachment Morphology
1.13.3. Peculiarities of Surgery in the Pediatric Age Group, Specialized Surgical Instruments and Equipment for Young Children
1.13.4. Scleral Surgery in the Pediatric Age Group
1.13.5. Vitrectomy in the Pediatric Age Group
1.13.6. Post-Surgical Medical and Postural Treatment in Infancy
1.13.7. Visual Rehabilitation

1.14. Stickler’s Syndromes

1.14.1. Definition and Classification of Stickler Syndromes
1.14.2. Clinical Findings and Imaging Tests
1.14.3. Systemic and Ocular Treatment for the Disease
1.14.4. Current Treatment for Stickler Syndrome
1.14.5. Natural and Evolutionary History of the Disease

1.15. Marfan Syndrome

1.15.1. Definition and Genetic Study of the Disease
1.15.2. Systemic Spectrum of the Disease
1.15.3. Ocular Involvement in Marfan Disease
1.15.4. Ocular Clinical Findings
1.15.5. Applicable Treatments to Marfan Syndrome
1.15.6. Retinal Detachment in Marfan Syndrome
1.15.7. Natural and Evolutiona

A unique, crucial and decisive learning experience to boost your professional development"